The Drugs tag covers a broad spectrum of pharmaceutical, legal, and public health developments, ranging from the latest breakthroughs in medical treatments and obesity management to the geopolitical and societal impacts of the global opioid crisis. Our coverage integrates expert analysis from leading international outlets like the Financial Times, Bloomberg, and the Wall Street Journal to track how pharmaceutical innovation, regulatory policy, and substance-related incidents shape global markets and public safety.